Link in Bio. 📈 Pot stocks spiked immediately after President Joe Biden announced the reclassification of ca**abis from a Schedule I to a Schedule III substance, endorsing the Justice Department’s recommendation. Once the DOJ publishes its proposed rule in the Federal Register this week, a 60-day public comment period will take place before the rule may be finalized. Multi-state operators (MSOs) would benefit the most from the Schedule III classification, like Canopy Growth, Curaleaf Holdings, Green Thumb Industries, and Trulieve, with operations in about three dozen states that allow sales. For example, shares of Canopy Growth, an enormous Canadian producer that trades on the #NewYorkStockExchange, rose 15%, to $11.95, after the tweet, but it’s important to keep in perspective the overall picture. Despite the recent gains seen by MSOs, several related stocks are far below their 5-year highs. Reclassification doesn’t fix the gap between federal and state law, and it sparked some neg...